Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Anesthesiology. 2020 Mar;132(3):551–561. doi: 10.1097/ALN.0000000000003016

Figure 1. Perioperative plasma expression of F2-isoprostanes, isofurans, ubiquitin carboxyl-terminal hydrolase isozyme L1, and S100 calcium binding protein B.

Figure 1.

Plasma concentrations of markers of oxidative damage (F2-isoprostanes, Panel A and isofurans, Panel B), neuronal injury (ubiquitin carboxyl-terminal hydrolase isozyme L1, Panel C), and blood-brain barrier disruption (S100 calcium binding protein B, Panel D) during the perioperative period in patients who developed delirium and those who did not develop delirium.